ALOXE3
protein-codingarachidonate lipoxygenase 3, the group of Arachidonate lipoxygenases
Gene summary
This gene is a member of the lipoxygenase family, which are catabolized by arachidonic acid-derived compounds. The encoded enzyme is a hydroperoxide isomerase that synthesizes a unique type of epoxy alcohol (8R-hydroxy-11R,12R-epoxyeicosa-5Z,9E,14Z-trienoic acid) from 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE). This epoxy alcohol can activate the the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha), which is implicated in epidermal differentiation. Loss of function of the enzyme encoded by this gene results in ichthyosis, implicating the function of this gene in the differentiation of human skin. This gene is part of a cluster of lipoxygenase genes on 17p13.1. Mutations in this gene result in nonbullous congenital ichthyosiform erythroderma (NCIE). Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~23.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019306
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0017778
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0017267
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011680
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011680
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011680
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0011680
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019306
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALOXE3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021628.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 29 | 3 | 38 | |
| missense | 9 | 14 | 135 | 18 | 3 | 179 |
| nonsense | 14 | 7 | 2 | 23 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 12 | 6 | 18 | |||
| splice donor/acceptor (+/-2bp) | 8 | 9 | 17 | |||
| Total | 45 | 36 | 143 | 47 | 6 | 277 |
Highest pathogenic variant AF is 0.0017414975
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_067641.2 | 15 | MANE Select | |
| Ensembl | ENSP00000400581.2 | 15 | MANE Select | |
| RefSeq | NP_001159432.1 | 16 | Standard | |
| RefSeq | NP_001356375.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of lipids
- Synthesis of 12-eicosatetraenoic acid derivatives
- Arachidonic acid metabolism
- Metabolism
- Fatty acid metabolism
Biological Process
- sphingolipid metabolic process
- sensory perception of pain
- arachidonic acid metabolic process
- lipoxygenase pathway
- peroxisome proliferator activated receptor signaling pathway
Molecular Function
- iron ion binding
- protein binding
- oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
- lyase activity
- hepoxilin A3 synthase activity
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000318227
- Coding exons
- 16
- Length
- 23148
- Individuals with no LoFs
- 125636
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 112
- Defined
- 125748
- p
- 0.000445
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.149 | 471 | 480 | 0.981 | 0.0000276 | 5441 |
| Missense (PolyPhen) | 145 | 160.07 | 0.90586 | 1963 | ||
| Synonymous | 0.414 | 196 | 204 | 0.963 | 0.0000116 | 1717 |
| Loss of Function | 1.26 | 35 | 44.0 | 0.795 | 0.00000235 | 458 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00026 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00087 | 0.00087 | rare |
| Finnish | 0.00042 | 0.00042 | rare |
| European (Non-Finnish) | 0.00052 | 0.00052 | rare |
| South Asian | 0.00043 | 0.00042 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Non-heme iron-containing lipoxygenase which is atypical in that it displays a prominent hydroperoxide isomerase activity and a reduced dioxygenase activity compared to other lipoxygenases. The hydroperoxide isomerase activity catalyzes the isomerization of hydroperoxides, derived from arachidonic and linoleic acid by ALOX12B, into hepoxilin-type epoxyalcohols. The dioxygenase activity requires a step of activation of the enzyme by molecular oxygen. In presence of oxygen, oxygenates polyunsaturated fatty acids, including arachidonic acid, to produce fatty acid hydroperoxides. In the skin, acts downstream of ALOX12B on the linoleate moiety of esterified omega-hydroxyacyl- sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins. Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss. In parallel, it may have a signaling function in barrier formation through the production of hepoxilins metabolites. Plays also a role in adipocyte differentiation through hepoxilin A3 and hepoxilin B3 production which in turn activate PPARG. Through the production of hepoxilins in the spinal cord, it may regulate inflammatory tactile allodynia. {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226, ECO:0000269|PubMed:20923767, ECO:0000269|PubMed:21558561}.;
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- LoFtool
- 0.146
- RVIS EVS
- -1
- RVIS percentile EVS
- 8.54
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.447
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |